One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common painkiller to autism, which the company is fighting.

Kenvue’s stock, which had hit a record low in recent weeks, was headed for its best day ever, while Kimberly-Clark’s stock tumbled.

On Monday, Kimberly-Clark, the company behind Kleenex, Huggies and Kotex, agreed to acquire Kenvue, the owner of Tylenol, Band-Aid and Neutrogena, in a cash and stock deal valued at approximately $48.7 billion. The move will create one of the world’s largest consumer staples and health goods companies, per CNBC.

Kimberly-Clark on Monday said it is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, combining the Huggies manufacturer with the owner of Aveeno and Band-Aid.

The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a common pain reliever is linked to autism.

(CNN)– Kimberly Clark, the maker of Huggies is buying Kenvue the parent company of Tylenol. Company officials say this nearly $50 billion deal brings together ten major brands, and will push yearly revenue to $32 billion.

Kimberly-Clark's nearly $50 billion offer for Tylenol maker Kenvue is a risky bet that the world's biggest consumer market, the United States, will keep growing even as lower-income shoppers trim their budgets,

Kimberly-Clark, in partnership with Cartology, has launched Australia’s first touch and feel point of sale baby aisle campaign to support the new Huggies Pure and Sensitive nappies. The innovative use of Retail Media brings the product’s key benefit to life,

Kimberly-Clark Corp, the company behind popular brands like Kleenex and Huggies, has announced its plan to acquire Kenvue Inc. The deal, worth around $40 billion in cash and stock, will see Kimberly-Clark take over the maker of Tylenol.

Kimberly-Clark shares were on track for their biggest one-day drop since the 1980s after the Huggies diapers maker agreed to buy Kenvue. Shares in the Tylenol maker leapt. In recent trading: Kimberly-